# Introduction to SAMueL-2 (Stroke Audit Machine Learning)

**Use of simulation and machine learning to identify key levers for maximising the disability benefit of intravenous thrombolysis in acute stroke pathways**

```{epigraph}
"Your decision to treat or not treat … That’s the difficult part. That’s the grey area where everyone does a different thing."

-- Stroke Consultant during interviews for SAMueL-1
```


